KDM5B drives the progression of cardiac fibrosis and facilitates adverse cardiac remodeling in response to ischemic or hypertrophic stress, which will aid in the development of novel epigenetic therapies for pathological cardiac fibrosis and heart failure. The gene discussed is KDM5B; the disease is heart failure.